Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Sonny7on Feb 22, 2018 3:54pm

111 Views

Post# 27604640

RE:RE:Medtronics provides SVA with CGM's for Clinical Trials

What would be your thoughts, caliente?

The news release showing involvement of Medtronic to the SVA trials was labeled a collaboration. I believe that Medtronic knows that they would have their pumps rendered obsolete with results showing success in the trials. The use of insulin pumps would be reduced to only being effective as duck decoy anchors and would mean a significant loss of revenue to Medtronic. With their participation in the trials they have their finger on the pulse and can act accordingly with results of the trial as they become available. This news could/should also be something to tweak interest in other companies who may be looking at Sernova. I like it.
my opinion

Bullboard Posts

Day trading vs. swing trading strategies for small-cap stocks